… trials have shown this strategy to be … the treatment pyramid for patients with recent-onset
rheumatoid arthritis. In this report, we describe the first-year results of a randomized clinical trial …

… This study in the first-line treatment of metastatic colorectal … Earlier randomized trials
comparing infusional to bolus FU/… In a previous Intergroup study of first-line therapy for metastatic …

… a first-line phase III randomized clinical trial on metastatic colorectal cancer (mCRC) aimed
at evaluating the effectiveness of adding bevacizumab (B) to standard first-line chemotherapy …

… has shown potential anticancer effects in preclinical and clinical studies. We aimed to establish
whether bisphosphonates can affect clinical outcomes in patients with multiple myeloma. …

… (FU)/folinic acid (FA) in the first-line therapy of metastatic colorectal cancer (CRC) has been
associated in randomized clinical trials with an increase in the median overall survival of …

… We performed a randomized controlled trial comparing intravenous pulse therapy with
methylprednisolone and decompressive surgery. The eligible patients were all consecutive …

… Our study was a three-arm randomized open-label phase II study comparing … as first-line
therapy for lung adenocarcinoma patients harboring sensitive EGFR mutations. The study was …

… as first-line therapy, but also that the surrogate index, blood-pressure lowering, is not a
consistent and valid marker of the therapeutic benefit of all antihypertensive agents. The value of …

… clinical trial that evaluated the efficacy and safety of single agent of capecitabine was the
maintenance therapy after first-line … and comparable with that of other similar studies [10., 11., 12…

… Thirty-nine randomized controlled trials were identified containing a total of 87 treatment …
of randomized controlled trials of first-line chemotherapy for MCRC to date, and included recent …